Search clinical trials for: RO5045377

Total 8 results

Hoffmann-La Roche

Completed

A Study of RO5045337 in Patients With Liposarcomas Prior to Debulking Surgery

Sarcoma

France
Hoffmann-La Roche

Completed

A Study of RO5045337 [RG7112] in Patients With Hematologic Neoplasms.

Hematologic Neoplasms

United States, Canada, United Kingdom, Italy
Hoffmann-La Roche

Completed

A Study of RO5045337 [RG7112] in Patients With Advanced Solid Tumors

Neoplasms

France, United States
Hoffmann-La Roche

Completed

A Study of RO5045337 in Patients With Solid Tumors

Neoplasms

United States
Hoffmann-La Roche

Completed

An Extension Study of RO5045337 in Participants Participating in Previous Roche-sponsored Cancer Studies

Myelogenous Leukemia, Chronic, Neoplasms, Myelogenous Leukemia, Acute

United States, France, Canada
Hoffmann-La Roche

Completed

A Study of RO5045337 in Combination With Cytarabine in Patients With Acute Myelogenous Leukemia

Myelogenous Leukemia, Acute

Canada, United States, United Kingdom, France, Italy
Shimaa M. Abdelgawad

Completed

Standardized Olive Leaf Capsules; as a Co-therapy in the Treatment of COVID-19 Patients

Covid19 | COVID-19 Respiratory Infection | Symptoms and Signs | Disseminated Intravascular Coagulation | COVID-19 Acute Bronchitis

Egypt
Hoffmann-La Roche

Completed

A Study of RO5045337 in Combination With Doxorubicin in Patients With Soft Tissue Sarcoma

Sarcoma

France, United States

3

Subscribe